Lowinger Timothy B
SVP, Chief Sci.&Tech. Officer at Mersana Therapeutics, Inc.
- Sold, on record
- $2.1M
- Dollars the filings state
- Form 4 sales
- 24
- Latest Jan 16, 2025
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Mersana Therapeutics, Inc.SVP, Chief Sci.&Tech. Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Mersana Therapeutics, Inc.Plan not statedJan 17, 2023 2023
Sold 6,233 shares at $5.74 ($36k)
Lowinger Timothy B, SVP, Chief Sci.&Tech. Off.
Sold 3.3% of holdings ($1.1M position)180,363 shares left1.5x usual sizeFiling
- 2 Form 144 notice Mersana Therapeutics, Inc.NoticeJan 16, 2024 +364 days
Filed to sell 10,409 shares ($31k)
Lowinger Timothy B, Officer
10b5-1 planFiling
- 3 Form 4 sale Mersana Therapeutics, Inc.RoutineJan 16, 2024 same day
Sold 10,409 shares at $2.71 ($28k)
Lowinger Timothy B, SVP, Chief Sci.&Tech. Officer
10b5-1 planSold 5% of holdings ($568k position)199,329 shares leftFollows a Form 144Filing
- 4 Form 4 sale Mersana Therapeutics, Inc.RoutineOct 3, 2024 +261 days
Sold 13,687 shares at $1.98 ($27k)
Lowinger Timothy B, SVP, Chief Sci.&Tech. Officer
10b5-1 planSold 5.5% of holdings ($495k position)235,642 shares leftFiling
- 5 Form 144 notice Mersana Therapeutics, Inc.NoticeOct 7, 2024 +4 days
Filed to sell 13,687 shares ($28k)
Lowinger Timothy B, Officer
10b5-1 plan1.3x usual sizeFiling
- 6 Form 4 sale Mersana Therapeutics, Inc.RoutineJan 14, 2025 +99 days
Sold 3,483 shares at $0.66 ($2k)
Lowinger Timothy B, SVP, Chief Sci.&Tech. Officer
10b5-1 planSold 1.4% of holdings ($163k position)242,932 shares left0.3x usual sizeFiling
- 7 Form 4 sale Mersana Therapeutics, Inc.RoutineJan 15, 2025 +1 day
Sold 1,794 shares at $0.63 ($1k)
Lowinger Timothy B, SVP, Chief Sci.&Tech. Officer
10b5-1 planSold 0.7% of holdings ($156k position)245,930 shares left0.2x usual sizeFiling
- 8 Form 4 sale Mersana Therapeutics, Inc.RoutineJan 16, 2025 +1 day
Sold 8,048 shares at $0.58 ($5k)
Lowinger Timothy B, SVP, Chief Sci.&Tech. Officer
10b5-1 planSold 3% of holdings ($154k position)257,673 shares left1.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (26)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2025 | Jan 17, 2025 | Mersana Therapeutics, Inc. | SVP, Chief Sci.&Tech. Officer | Form 4 sale | 8,048 | $5k | 3.0% | Routine | SEC |
| Jan 15, 2025 | Jan 16, 2025 | Mersana Therapeutics, Inc. | SVP, Chief Sci.&Tech. Officer | Form 4 sale | 1,794 | $1k | 0.7% | Routine | SEC |
| Jan 14, 2025 | Jan 15, 2025 | Mersana Therapeutics, Inc. | SVP, Chief Sci.&Tech. Officer | Form 4 sale | 3,483 | $2k | 1.4% | Routine | SEC |
| Oct 7, 2024 | Oct 7, 2024 | Mersana Therapeutics, Inc. | Officer | Form 144 notice | 13,687 | $28k | Notice | SEC | |
| Oct 3, 2024 | Oct 7, 2024 | Mersana Therapeutics, Inc. | SVP, Chief Sci.&Tech. Officer | Form 4 sale | 13,687 | $27k | 5.5% | Routine | SEC |
| Jan 16, 2024 | Jan 17, 2024 | Mersana Therapeutics, Inc. | SVP, Chief Sci.&Tech. Officer | Form 4 sale | 10,409 | $28k | 5.0% | Routine | SEC |
| Jan 16, 2024 | Jan 16, 2024 | Mersana Therapeutics, Inc. | Officer | Form 144 notice | 10,409 | $31k | Notice | SEC | |
| Jan 17, 2023 | Jan 18, 2023 | Mersana Therapeutics, Inc. | SVP, Chief Sci.&Tech. Off. | Form 4 sale | 6,233 | $36k | 3.3% | Plan not stated | SEC |
| Jan 18, 2022 | Jan 19, 2022 | Mersana Therapeutics, Inc. | Chief Science & Tech Off. | Form 4 sale | 4,741 | $28k | 3.5% | Plan not stated | SEC |
| Aug 20, 2021 | Aug 24, 2021 | Mersana Therapeutics, Inc. | Chief Science & Tech. Officer | Form 4 sale | 2,216 | $24k | 2.9% | Plan not stated | SEC |
| Jul 20, 2021 | Jul 22, 2021 | Mersana Therapeutics, Inc. | Chief Science & Tech. Officer | Form 4 sale | 2,227 | $27k | 2.9% | Plan not stated | SEC |
| Jul 19, 2021 | Jul 19, 2021 | Mersana Therapeutics, Inc. | Chief Science & Tech. Officer | Form 4 sale | 16,271 | $199k | 17.8% | Plan not stated | SEC |
| Jul 1, 2021 | Jul 2, 2021 | Mersana Therapeutics, Inc. | CS & Technology Officer | Form 4 sale | 1,886 | $26k | 5.7% | Plan not stated | SEC |
| Jun 21, 2021 | Jun 23, 2021 | Mersana Therapeutics, Inc. | Chief Science & Tech. Officer | Form 4 sale | 2,220 | $31k | 6.6% | Plan not stated | SEC |
| May 20, 2021 | May 24, 2021 | Mersana Therapeutics, Inc. | Chief Science & Tech. Officer | Form 4 sale | 4,102 | $58k | 11.5% | Plan not stated | SEC |
| Apr 20, 2021 | Apr 22, 2021 | Mersana Therapeutics, Inc. | Chief Science & Tech. Officer | Form 4 sale | 4,102 | $65k | 11.5% | Plan not stated | SEC |
| Mar 22, 2021 | Mar 24, 2021 | Mersana Therapeutics, Inc. | Chief Science & Tech. Officer | Form 4 sale | 8,203 | $144k | 20.7% | Plan not stated | SEC |
| Feb 22, 2021 | Feb 24, 2021 | Mersana Therapeutics, Inc. | Chief Science & Tech. Officer | Form 4 sale | 8,203 | $164k | 20.7% | Plan not stated | SEC |
| Jan 20, 2021 | Jan 22, 2021 | Mersana Therapeutics, Inc. | Chief Science & Tech. Officer | Form 4 sale | 8,203 | $177k | 20.7% | Plan not stated | SEC |
| Dec 21, 2020 | Dec 22, 2020 | Mersana Therapeutics, Inc. | Chief Science & Tech. Officer | Form 4 sale | 8,203 | $210k | 100.0% | Unusual | SEC |
| Nov 20, 2020 | Nov 24, 2020 | Mersana Therapeutics, Inc. | Chief Science & Tech. Officer | Form 4 sale | 8,203 | $189k | 100.0% | Unusual | SEC |
| Oct 21, 2020 | Oct 22, 2020 | Mersana Therapeutics, Inc. | Chief Science & Tech. Officer | Form 4 sale | 8,203 | $140k | 32.7% | Unusual | SEC |
| Sep 21, 2020 | Sep 23, 2020 | Mersana Therapeutics, Inc. | Chief Science, Tech. Officer | Form 4 sale | 20,614 | $426k | 100.0% | Unusual | SEC |
| Sep 24, 2018 | Sep 25, 2018 | Mersana Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 3,500 | $41k | 21.9% | Plan not stated | SEC |
| Aug 27, 2018 | Aug 29, 2018 | Mersana Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 3,500 | $46k | 21.9% | Plan not stated | SEC |
| Jul 23, 2018 | Jul 25, 2018 | Mersana Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 3,500 | $39k | 21.9% | Plan not stated | SEC |